These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 9261943

  • 1. Expression of a synthetic pertussis toxin operon in Escherichia coli.
    Pozza TD, Yan H, Walker MJ.
    Vaccine; 1997 Jun; 15(9):968-75. PubMed ID: 9261943
    [Abstract] [Full Text] [Related]

  • 2. Construction and characterisation of Salmonella typhimurium aroA simultaneously expressing the five pertussis toxin subunits.
    Dalla Pozza T, Yan H, Meek D, Guzmán CA, Walker MJ.
    Vaccine; 1998 Mar; 16(5):522-9. PubMed ID: 9491507
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Promoter of the pertussis toxin operon and production of pertussis toxin.
    Nicosia A, Rappuoli R.
    J Bacteriol; 1987 Jun; 169(6):2843-6. PubMed ID: 2438270
    [Abstract] [Full Text] [Related]

  • 6. Construction and characterization of Bordetella pertussis toxin mutants.
    Black WJ, Falkow S.
    Infect Immun; 1987 Oct; 55(10):2465-70. PubMed ID: 2888733
    [Abstract] [Full Text] [Related]

  • 7. Expression and secretion of pertussis toxin subunit S1 in Bacillus subtilis.
    Runeberg-Nyman K, Engström O, Löfdahl S, Ylöstalo S, Sarvas M.
    Microb Pathog; 1987 Dec; 3(6):461-8. PubMed ID: 2904640
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Construction of minitransposons for constitutive and inducible expression of pertussis toxin in bvg-negative Bordetella bronchiseptica.
    Walker MJ, Rohde M, Wehland J, Timmis KN.
    Infect Immun; 1991 Nov; 59(11):4238-48. PubMed ID: 1682257
    [Abstract] [Full Text] [Related]

  • 10. Pertussis toxin gene: nucleotide sequence and genetic organization.
    Locht C, Keith JM.
    Science; 1986 Jun 06; 232(4755):1258-64. PubMed ID: 3704651
    [Abstract] [Full Text] [Related]

  • 11. Characterization of mutant strains producing pertussis toxin cross reacting materials.
    Sato Y, Sato H, Chazono M, Ginnaga A, Tamura C.
    Dev Biol Stand; 1991 Jun 06; 73():93-107. PubMed ID: 1778339
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Co-expression of the Bordetella pertussis leader peptidase I results in enhanced processing and expression of the pertussis toxin S1 subunit in Escherichia coli.
    Smith AM, Yan H, Groves N, Dalla Pozza T, Walker MJ.
    FEMS Microbiol Lett; 2000 Oct 15; 191(2):177-82. PubMed ID: 11024260
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Engineering of genetically detoxified pertussis toxin analogs for development of a recombinant whooping cough vaccine.
    Loosmore SM, Zealey GR, Boux HA, Cockle SA, Radika K, Fahim RE, Zobrist GJ, Yacoob RK, Chong PC, Yao FL.
    Infect Immun; 1990 Nov 15; 58(11):3653-62. PubMed ID: 2228237
    [Abstract] [Full Text] [Related]

  • 17. Expression and immunological properties of the five subunits of pertussis toxin.
    Nicosia A, Bartoloni A, Perugini M, Rappuoli R.
    Infect Immun; 1987 Apr 15; 55(4):963-7. PubMed ID: 3549567
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.